The team at Jones Day handles the full gamut of issues for a varied client roster of pharmaceutical companies, research institutes, and medical device manufacturers. Leveraging its network across the European Union, the firm advises on numerous digital health matters, pre-market clinical trials, and post-market studies. Practice head Cristiana Spontoni is known for acting on a variety of matters concerning product regulation, in addition to both pre and post-market issues relating to product liability, distribution, and data privacy. Ursula Schliessner maintains a health and safety focused practice, while Jörg Hladjk focuses on privacy and cybersecurity mandates, regularly advising research centers and medical device companies.

Legal 500 Editorial commentary

Key clients

  • Arsenal Capital
  • Astellas Pharma Inc.
  • BioMarin Pharmaceutical Inc.
  • Cellectis SA
  • Institut Pasteur
  • International PNH Interest Group
  • Lipton Teas and Infusions
  • MedTech Europe
  • Pharmaceutical Product Development
  • Shiseido
  • Sumitomo Dainippon Pharma

Work highlights

  • Representing BioMarin, a company involved in developing and commercialising innovative biopharmaceuticals for rare diseases driven by genetic causes, in a wide array of regulatory, legal, and litigation matters.
  • Advising Sumitomo Dainippon Pharma on a wide variety of ongoing regulatory and legal matters on a pan-European and global basis.
  • Advising Institut Pasteur on an array of EU-wide and global regulatory and legal matters.

Practice head

The lawyer(s) leading their teams.

Cristiana Spontoni

Other key lawyers

Ursula Schliessner, Jörg Hladjk